• Je něco špatně v tomto záznamu ?

Subtype differences in pre-coupling of muscarinic acetylcholine receptors

J. Jakubík, H. Janíčková, A. Randáková, EE. El-Fakahany, V. Doležal,

. 2011 ; 6 (11) : e27732. [pub] 20111116

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12022556

Based on the kinetics of interaction between a receptor and G-protein, a myriad of possibilities may result. Two extreme cases are represented by: 1/Collision coupling, where an agonist binds to the free receptor and then the agonist-receptor complex "collides" with the free G-protein. 2/Pre-coupling, where stable receptor/G-protein complexes exist in the absence of agonist. Pre-coupling plays an important role in the kinetics of signal transduction. Odd-numbered muscarinic acetylcholine receptors preferentially couple to G(q/11), while even-numbered receptors prefer coupling to G(i/o). We analyzed the coupling status of the various subtypes of muscarinic receptors with preferential and non-preferential G-proteins. The magnitude of receptor-G-protein coupling was determined by the proportion of receptors existing in the agonist high-affinity binding conformation. Antibodies directed against the C-terminus of the α-subunits of the individual G-proteins were used to interfere with receptor-G-protein coupling. Effects of mutations and expression level on receptor-G-protein coupling were also investigated. Tested agonists displayed biphasic competition curves with the antagonist [(3)H]-N-methylscopolamine. Antibodies directed against the C-terminus of the α-subunits of the preferential G-protein decreased the proportion of high-affinity sites, and mutations at the receptor-G-protein interface abolished agonist high-affinity binding. In contrast, mutations that prevent receptor activation had no effect. Expression level of preferential G-proteins had no effect on pre-coupling to non-preferential G-proteins. Our data show that all subtypes of muscarinic receptors pre-couple with their preferential classes of G-proteins, but only M(1) and M(3) receptors also pre-couple with non-preferential G(i/o) G-proteins. Pre-coupling is not dependent on agonist efficacy nor on receptor activation. The ultimate mode of coupling is therefore dictated by a combination of the receptor subtype and the class of G-protein.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12022556
003      
CZ-PrNML
005      
20120906132111.0
007      
ta
008      
120806e20111116xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0027732 $2 doi
035    __
$a (PubMed)22110745
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Jakubík, Jan $u Department of Neurochemistry, Institute of Physiology Academy of Sciences of the Czech Republic v.v.i., Prague, Czech Republic. jakubik@biomed.cas.cz
245    10
$a Subtype differences in pre-coupling of muscarinic acetylcholine receptors / $c J. Jakubík, H. Janíčková, A. Randáková, EE. El-Fakahany, V. Doležal,
504    __
$a $b
520    9_
$a Based on the kinetics of interaction between a receptor and G-protein, a myriad of possibilities may result. Two extreme cases are represented by: 1/Collision coupling, where an agonist binds to the free receptor and then the agonist-receptor complex "collides" with the free G-protein. 2/Pre-coupling, where stable receptor/G-protein complexes exist in the absence of agonist. Pre-coupling plays an important role in the kinetics of signal transduction. Odd-numbered muscarinic acetylcholine receptors preferentially couple to G(q/11), while even-numbered receptors prefer coupling to G(i/o). We analyzed the coupling status of the various subtypes of muscarinic receptors with preferential and non-preferential G-proteins. The magnitude of receptor-G-protein coupling was determined by the proportion of receptors existing in the agonist high-affinity binding conformation. Antibodies directed against the C-terminus of the α-subunits of the individual G-proteins were used to interfere with receptor-G-protein coupling. Effects of mutations and expression level on receptor-G-protein coupling were also investigated. Tested agonists displayed biphasic competition curves with the antagonist [(3)H]-N-methylscopolamine. Antibodies directed against the C-terminus of the α-subunits of the preferential G-protein decreased the proportion of high-affinity sites, and mutations at the receptor-G-protein interface abolished agonist high-affinity binding. In contrast, mutations that prevent receptor activation had no effect. Expression level of preferential G-proteins had no effect on pre-coupling to non-preferential G-proteins. Our data show that all subtypes of muscarinic receptors pre-couple with their preferential classes of G-proteins, but only M(1) and M(3) receptors also pre-couple with non-preferential G(i/o) G-proteins. Pre-coupling is not dependent on agonist efficacy nor on receptor activation. The ultimate mode of coupling is therefore dictated by a combination of the receptor subtype and the class of G-protein.
650    _2
$a zvířata $7 D000818
650    _2
$a kompetitivní vazba $7 D001667
650    _2
$a CHO buňky $7 D016466
650    _2
$a karbachol $x metabolismus $7 D002217
650    _2
$a křečci praví $7 D006224
650    _2
$a Cricetulus $7 D003412
650    _2
$a proteiny vázající GTP $x metabolismus $7 D019204
650    _2
$a guanosin 5'-O-(3-thiotrifosfát) $x metabolismus $7 D016244
650    _2
$a lidé $7 D006801
650    _2
$a kinetika $7 D007700
650    _2
$a mutace $7 D009154
650    _2
$a N-methylskopolamin $x metabolismus $7 D019832
650    _2
$a receptory muskarinové $x genetika $x metabolismus $7 D011976
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Janíčková, Helena
700    1_
$a Randáková, Alena
700    1_
$a El-Fakahany, Esam E
700    1_
$a Doležal, Vladimír
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 6, č. 11 (20111116), s. e27732
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22110745 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120806 $b ABA008
991    __
$a 20120906132242 $b ABA008
999    __
$a ok $b bmc $g 944469 $s 779853
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 6 $c 11 $d e27732 $e 20111116 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20120806/12/01

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...